OpenNeedle Ask your own

Question explored with the scientific record

Conversation so far

  1. 1 Dihydrocodiene long termmuse
  2. 2 Are there any studies specifically on long-term dihydrocodeine harms?

Answered on this page ↓

Are there any studies specifically on long-term dihydrocodeine harms?

Sep 3, 2026 · 5 sources used · OpenNeedle synthesis
The short version: there are no studies here that test long-term dihydrocodeine harms directly. The evidence is about other opioids and other topics entirely.

The retrieval surfaced one safety review of dihydrocodeine from 2015 [1], but it covers general adverse effects and dosing limits, not long-term outcomes. It reports that dihydrocodeine contributed to 6.8% of opioid-related deaths in the UK over a decade [1], which is a population signal, not a controlled study of chronic use. A 2017 trial in Chest tested dihydrocodeine's effect on breathing during a single dose in chronic cough patients [2] — that is an acute effect, not long-term harm. The other three records are about bariatric surgery, kidney transplant tolerance, and phenylketonuria treatment [3, 4, 5]. They have nothing to do with dihydrocodeine.

So the evidence base for your question is essentially absent from this retrieval. No study here followed people on dihydrocodeine for months or years and measured harms. No study compared long-term users to non-users. The safety review [1] is the closest thing, and it is a narrative summary, not a prospective cohort or trial. The acute respiratory depression finding [2] is relevant to overdose risk but tells you nothing about dependence, cognitive decline, constipation, or hyperalgesia over time.

What you can say from the opioid class literature outside this retrieval is that long-term opioid use carries well-documented risks. But that is general knowledge, not evidence specific to dihydrocodeine. The question you asked — are there studies specifically on long-term dihydrocodeine harms — is answered by this retrieval with a clear no.

My call: the evidence here does not include a single study on long-term dihydrocodeine harms. Confidence: high that this retrieval contains none.

Keep digging

Sources used 5

  1. Dihydrocodeine: safety concerns Expert Review of Clinical Pharmacology (2015) Thin

    This article provides a comprehensive safety review of dihydrocodeine (DHC), detailing its potency relative to other opioids, common and serious adverse effects, dosing limits, drug interactions, special risk factors (notably in the elderly and renal impairment), and practical c…

    DOI: 10.1586/17512433.2016.1092871
  2. A Randomized Clinical Trial Comparing the Effects of Antitussive Agents on Respiratory Center Output in Patients With Chronic Cough Chest (2017) Thin

    This study investigates the effects of the non-opioid antitussive Levodropropizine compared to the opioid Dihydrocodeine on respiratory responses in patients with chronic cough, finding that Levodropropizine does not significantly affect ventilation during hypercapnia, unlike Di…

    DOI: 10.1016/j.chest.2017.02.001
  3. Long-Term Food Tolerance After Bariatric Surgery: Comparison of Three Different Surgical Techniques Obesity Surgery (2017) Thin

    This study evaluates long-term food tolerance in obese patients after bariatric surgery, comparing outcomes among three surgical techniques: gastric bypass, modified biliopancreatic diversion, and modified duodenal switch, finding no significant differences in food tolerance sco…

    DOI: 10.1007/s11695-017-2703-9
  4. LONG-TERM FOLLOW-UP OF KIDNEY TRANSPLANT PATIENTS WITH POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER Transplantation (2003) Thin

    In 12 kidney transplant patients with posttransplant lymphoproliferative disorder (PTLD), cessation of immunosuppression led to PTLD resolution and long-term graft tolerance in most cases, five patients underwent retransplantation without PTLD recurrence, and serial IL-18 measur…

    DOI: 10.1097/01.tp.0000072015.08302.e9
  5. Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria Molecular Genetics and Metabolism (2005) Thin

    A 5-year clinical study showing that long-term tetrahydrobiopterin (BH4) treatment increases phenylalanine tolerance and relaxes dietary restrictions in a subset of children with severe PKU who are BH4-responsive, expanding BH4 responsiveness beyond mild PKU and improving qualit…

    DOI: 10.1016/j.ymgme.2005.05.013

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question